ARTEMISMED Shareholding Pattern: Promoter, FII & DII Holding (ARTEMISMED)

ARTEMISMED latest shareholding pattern: promoter holding, FII / FPI holding, DII and mutual fund holding, public holding and number of shareholders, quarter by quarter.

  • ARTEMISMED Financials
  • ARTEMISMED Shareholding Pattern
  • ARTEMISMED Earnings Documents
  • ARTEMISMED Announcements
  • ARTEMISMED Corporate Actions
  • ARTEMISMED Bulk, Block & Insider Deals
  • ARTEMISMED Delivery Data
  • ARTEMISMED Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Artemis Medicare Services Ltd (ARTEMISMED) Shareholding Pattern - Promoter, FII, DII & Public Holdings

As of Sep 2026, promoters held 58.39% of Artemis Medicare Services Ltd, FIIs 12.45%, DIIs 1.91%, government 6.16% and the public 21.07%, across 44,260 shareholders.

ARTEMISMED shareholding pattern, quarterly (%)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters67.17%67.17%66.53%66.53%58.38%58.39%58.39%58.39%
FIIs0.65%0.31%0.24%0.37%12.47%12.19%12.28%12.45%
DIIs4.51%5.04%4.76%4.27%2.91%2.89%2.4%1.91%
Government7.09%7.09%7.02%7.02%6.16%6.16%6.16%6.16%
Public20.59%20.39%21.45%21.81%20.07%20.37%20.76%21.07%
No. of Shareholders27,00428,39731,61433,55931,60232,04436,33544,260
ARTEMISMED shareholding pattern, yearly (%)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Promoters69.82%68.91%68.03%67.17%58.39%58.39%
FIIs0%0%0.1%0.31%12.19%12.45%
DIIs1.1%1.37%2.61%5.04%2.89%1.91%
Government7.37%7.27%7.18%7.09%6.16%6.16%
Public21.71%22.43%22.08%20.39%20.37%21.07%
No. of Shareholders12,09818,10019,99328,39732,04444,260
  • ARTEMISMED Financials
  • ARTEMISMED Earnings Concalls
  • ARTEMISMED Growth Catalysts
  • ARTEMISMED Corporate Actions
  • ARTEMISMED Announcements
  • ARTEMISMED Results & Documents
  • ARTEMISMED Bulk & Block Deals
  • ARTEMISMED Delivery Data